The National Health Service has escalated a major national patient safety alert, warning millions across the UK about the potentially deadly side effects of commonly used painkillers.
A recent safety review by the Medicines and Healthcare products Regulatory Agency (MHRA) has uncovered alarming evidence linking Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) to a significantly increased risk of catastrophic cardiovascular events.
Which Medications Are Affected?
The alert specifically targets widely available NSAIDs, including:
- Ibuprofen (found in Nurofen and Advil)
- Diclofenac
- Naproxen
- Celecoxib
- Etoricoxib
- Etodolac
- Indomethacin
- Piroxicam
These medications, both prescription-strength and those available over-the-counter, are now under intense scrutiny.
The Hidden Dangers: What the Review Found
The comprehensive safety review delivered disturbing findings. Even short-term use of these painkillers can dramatically increase the risk of:
- Heart failure
- Heart attacks
- Stroke
This risk is not limited to those with pre-existing heart conditions. The MHRA emphasises that all patients using these medications could be vulnerable.
New NHS Guidance for Patients and Clinicians
In response to these findings, the NHS has issued strict new prescribing guidelines. Healthcare professionals are now urged to:
- Avoid prescribing NSAIDs to patients with serious underlying heart conditions.
- Use the lowest effective dose for the shortest possible duration for all patients.
- Conduct thorough cardiovascular risk assessments before initiating any NSAID treatment.
For the public, the message is clear: do not stop taking your medication abruptly. Instead, consult your GP or pharmacist immediately to discuss your concerns and review your treatment options.
This alert serves as a crucial reminder that even the most common medicines carry risks, underscoring the importance of vigilant monitoring and professional medical advice.
